|
| 37066238 | Investigating The Relationship Between Hippocampus:Dentate Gyrus Volume and Hypothalamus Metabolism in Participants with Major Depressive Disorder. | Res Sq | 2023 |
| 37622759 | Reward Behavior Disengagement, a Neuroeconomic Model-Based Objective Measure of Reward Pathology in Depression: Findings from the EMBARC Trial. | Behav Sci (Basel) | 2023 |
| 37615234 | An improved synthesis of [<sup>18</sup> F]VAT and its precursor. | J Labelled Comp Radiopharm | 2023 |
| 35670301 | Alterations in resting-state functional activity and connectivity for major depressive disorder appetite and weight disturbance phenotypes. | Psychol Med | 2023 |
| 37120493 | Circadian rhythm biomarker from wearable device data is related to concurrent antidepressant treatment response. | NPJ Digit Med | 2023 |
| 33213541 | Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial. | Psychol Med | 2022 |
| 35680431 | Dynamic Resting-State Network Biomarkers of Antidepressant Treatment Response. | Biol Psychiatry | 2022 |
| 35688046 | Rejection sensitivity and mu opioid receptor dynamics associated with mood alterations in response to social feedback. | Psychiatry Res Neuroimaging | 2022 |
| 36439668 | Mu Opioid Receptor Dynamics in Healthy Volunteers with a History of Childhood Maltreatment. | J Child Adolesc Trauma | 2022 |
| 36699194 | Gradient boosting decision-tree-based algorithm with neuroimaging for personalized treatment in depression. | Neurosci Inform | 2022 |
| 35982258 | Does the change in glutamate to GABA ratio correlate with change in depression severity? A randomized, double-blind clinical trial. | Mol Psychiatry | 2022 |
| 36115855 | Evaluation of brain structure and metabolism in currently depressed adults with a history of childhood trauma. | Transl Psychiatry | 2022 |
| 35290819 | Neural substrates of emotional conflict with anxiety in major depressive disorder: Findings from the Establishing Moderators and biosignatures of Antidepressant Response in Clinical Care (EMBARC) randomized controlled trial. | J Psychiatr Res | 2022 |
| 32921587 | Dorsolateral Prefrontal Cortex and Subcallosal Cingulate Connectivity Show Preferential Antidepressant Response in Major Depressive Disorder. | Biol Psychiatry Cogn Neurosci Neuroimaging | 2021 |
| 34589784 | Neuroinflammation in World Trade Center responders at midlife: A pilot study using [<sup>18</sup>F]-FEPPA PET imaging. | Brain Behav Immun Health | 2021 |
| 34689056 | Measuring brain glucose metabolism in order to predict response to antidepressant or placebo: A randomized clinical trial. | Neuroimage Clin | 2021 |
| 33158553 | Characteristics of depressed suicide attempters with remitted substance use disorders. | J Psychiatr Res | 2021 |
| 33129637 | Examination of structural brain changes in recent suicidal behavior. | Psychiatry Res Neuroimaging | 2021 |
| 31537090 | Effect of Intrinsic Patterns of Functional Brain Connectivity in Moderating Antidepressant Treatment Response in Major Depression. | Am J Psychiatry | 2020 |
| 32055965 | Prediction of lithium treatment response in bipolar depression using 5-HTT and 5-HT<sub>1A</sub> PET. | Eur J Nucl Med Mol Imaging | 2020 |
| 31898087 | The importance of identifying functional Val158Met polymorphism in catechol-O- Methyltransferase when assessing MRI-based volumetric measurements in major depressive disorder. | Brain Imaging Behav | 2020 |
| 32065076 | Guidelines for the content and format of PET brain data in publications and archives: A consensus paper. | J Cereb Blood Flow Metab | 2020 |
| 32507389 | Pretreatment Reward Sensitivity and Frontostriatal Resting-State Functional Connectivity Are Associated With Response to Bupropion After Sertraline Nonresponse. | Biol Psychiatry | 2020 |
| 32169543 | Examining the underpinnings of loudness dependence of auditory evoked potentials with positron emission tomography. | Neuroimage | 2020 |
| 31388104 | Discovery and replication of cerebral blood flow differences in major depressive disorder. | Mol Psychiatry | 2020 |
| 31462766 | Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals. | Mol Psychiatry | 2020 |
| 29651896 | Cerebral serotonin transporter measurements with [<sup>11</sup>C]DASB: A review on acquisition and preprocessing across 21 PET centres. | J Cereb Blood Flow Metab | 2019 |
| 30166355 | Synthesis of Patient-Specific Transmission Data for PET Attenuation Correction for PET/MRI Neuroimaging Using a Convolutional Neural Network. | J Nucl Med | 2019 |
| 29962359 | Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC study. | Psychol Med | 2019 |
| 31356761 | In vivo PET Imaging of [11C]CIMBI-5, a 5-HT2AR Agonist Radiotracer in Nonhuman Primates. | J Pharm Pharm Sci | 2019 |
| 31193824 | Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC Trial. | EClinicalMedicine | 2019 |
| 31158720 | Examining raphe-amygdala structural connectivity as a biological predictor of SSRI response. | J Affect Disord | 2019 |
| 30962366 | Childhood trauma history is linked to abnormal brain connectivity in major depression. | Proc Natl Acad Sci U S A | 2019 |
| 30718038 | Pretreatment Rostral Anterior Cingulate Cortex Connectivity With Salience Network Predicts Depression Recovery: Findings From the EMBARC Randomized Clinical Trial. | Biol Psychiatry | 2019 |
| 30580237 | Resting regional brain activity correlates of verbal learning deficit in major depressive disorder. | Psychiatry Res Neuroimaging | 2019 |
| 30652941 | The Concise Health Risk Tracking-Self Report: Psychometrics within a placebo-controlled antidepressant trial among depressed outpatients. | J Psychopharmacol | 2019 |
| 30535672 | Quantification of Positron Emission Tomography Data Using Simultaneous Estimation of the Input Function: Validation with Venous Blood and Replication of Clinical Studies. | Mol Imaging Biol | 2019 |
| 30699849 | Anxiety and anhedonia in depression: Associations with neuroticism and cognitive control. | J Affect Disord | 2019 |
| 29519187 | Molecular connectivity disruptions in males with major depressive disorder. | J Cereb Blood Flow Metab | 2019 |
| 28888770 | Test-retest reliability of cerebral blood flow in healthy individuals using arterial spin labeling: Findings from the EMBARC study. | Magn Reson Imaging | 2018 |
| 30072617 | In Vivo Brain Imaging, Biodistribution, and Radiation Dosimetry Estimation of [<sup>11</sup>C]Celecoxib, a COX-2 PET Ligand, in Nonhuman Primates. | Molecules | 2018 |
| 29935119 | Kappa opioid receptor binding in major depression: A pilot study. | Synapse | 2018 |
| 29929881 | Radiosynthesis and in vivo evaluation of [<sup>11</sup>C]MOV as a PET imaging agent for COX-2. | Bioorg Med Chem Lett | 2018 |
| 29955151 | Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder. | Neuropsychopharmacology | 2018 |
| 30113112 | Development and evaluation of a multimodal marker of major depressive disorder. | Hum Brain Mapp | 2018 |
| 30110685 | A Novel Strategy to Identify Placebo Responders: Prediction Index of Clinical and Biological Markers in the EMBARC Trial. | Psychother Psychosom | 2018 |
| 30396759 | In vivo evaluation of [<sup>11</sup>C]TMI, a COX-2 selective PET tracer, in baboons. | Bioorg Med Chem Lett | 2018 |
| 30261974 | The Importance of Publishing Negative Findings in Science. | Biol Psychiatry | 2018 |
| 28397841 | Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [<sup>11</sup>C]ABP688 and PET imaging study in depression. | Mol Psychiatry | 2018 |
| 29702461 | Higher 5-HT<sub>1A</sub> autoreceptor binding as an endophenotype for major depressive disorder identified in high risk offspring - A pilot study. | Psychiatry Res Neuroimaging | 2018 |